Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after
Rohtesh S Mehta1, Antonio Di Stasi2, Chitra Hosing2
1Division of Hematology-Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA.
Clinical Lymphoma, Myeloma & Leukemia
|February 8, 2014
Abstract
No abstract available in PubMed .
More Related Videos
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.9K
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
7.3K
